Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram

被引:24
|
作者
Potts, A. L.
Young, K. L.
Carter, B. S.
Shenai, J. P.
机构
[1] Vanderbilt Childrens Hosp, Div Neonatol, Dept Pediat, Nashville, TN 37232 USA
[2] Vanderbilt Childrens Hosp, Dept Pharm, Nashville, TN USA
[3] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
关键词
necrotizing enterocolitis; SSRI; antidepressant; newborn; breastmilk;
D O I
10.1038/sj.jp.7211640
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described.
引用
收藏
页码:120 / 122
页数:3
相关论文
共 50 条
  • [11] Neonatal signs after in utero exposure to selective serotonin reuptake inhibitors
    Lavenstein, B
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (18): : 2300 - 2300
  • [12] In-utero Selective Serotonin Reuptake Inhibitor Antidepressant Exposure: Fetal Programing and Developmental Interactions With Context
    Park, Mina
    Oberlander, Tim F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (04) : 616 - 618
  • [13] Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes (vol 163, pg 949, 2009)
    Lund, Najaaraq
    Pedersen, Lars H.
    Henriksen, Tine Brink
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (12): : 1143 - 1143
  • [14] Serotonin Transporter Occupancy in Rats Exposed to Serotonin Reuptake Inhibitors In Utero or via Breast Milk
    Capello, Catherine F.
    Bourke, Chase H.
    Ritchie, James C.
    Stowe, Zachary N.
    Newport, D. Jeffrey
    Nemeroff, Amanda
    Owens, Michael J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (01): : 275 - 285
  • [15] Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain
    Rotem-Kohavi, Naama
    Williams, Lynne J.
    Virji-Babul, Naznin
    Bjornson, Bruce H.
    Brain, Ursula
    Werker, Janet F.
    Grunau, Ruth E.
    Miller, Steven P.
    Oberlander, Tim F.
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2019, 4 (01) : 39 - 49
  • [16] Embryo aneuploidy is not impacted by selective serotonin reuptake inhibitor exposure
    Hernandez-Nieto, Carlos
    Lee, Joseph
    Nazem, Taraneh
    Gounko, Dmitry
    Copperman, Alan
    Sandler, Benjamin
    FERTILITY AND STERILITY, 2017, 108 (06) : 973 - 979
  • [17] Excretion of selective serotonin reuptake inhibitors in breast milk.
    Nordeng, H
    Bergsholm, YK
    Bohler, E
    Spigset, O
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2001, 121 (02) : 199 - 203
  • [18] Effects of Selective Serotonin Reuptake Inhibitor Exposure on Markers of Osteogenesis
    Cray, James
    Khaksarfard, Kameron
    Weinberg, Seth
    Elsalanty, Mohammed
    Yu, Jack
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [19] In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
    Gidaya, Nicole B.
    Lee, Brian K.
    Burstyn, Igor
    Yudell, Michael
    Mortensen, Erik L.
    Newschaffer, Craig J.
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2014, 44 (10) : 2558 - 2567
  • [20] Exposure to selective serotonin reuptake inhibitors in utero and early elementary school outcomes
    Kragholm, K.
    Andersen, M. P.
    Mortensen, R. N.
    Bech, L. F.
    Polcwiartek, C.
    Rohde, C.
    Torp-Pedersen, C.
    Videbech, P.
    Nielsen, J.
    ACTA PSYCHIATRICA SCANDINAVICA, 2018, 137 (06) : 481 - 490